Showing 1 posts of 1 posts found.
GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …
How will biomarker-led diagnostics reshape respiratory medicine?
Five Facts about COPD
“That gap between innovation and delivery was what stood out to me most”
Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster
Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study